Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asako Yoritaka

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Medical Gas Research|February 5, 2019
Inhalation of hydrogen gas elevates urinary 8-hydroxy-2'-deoxyguanine in Parkinson's diseaseMasaaki Hirayama, Mikako Ito, Tomomi Minato, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 10, 2011
Cerebral infarction in a young man using high-dose anabolic steroidsYoshiaki Shimada, Asako Yoritaka, Yasutaka Tanaka, et al.
Parkinsonism & Related Disorders|January 10, 2009
Toxic effects of dopamine metabolism in Parkinson's diseaseNobutaka Hattoria, Mei Wanga, Hikari Taka, et al.
Parkinsonism & Related Disorders|June 10, 2015
Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's diseaseAsako Yoritaka, Sumihiro Kawajiri, Yorihiro Yamamoto, et al.
Journal of Parkinson'S Disease|May 3, 2014
Serum uric acid concentration is linked to wearing-off fluctuation in Japanese Parkinson's disease patientsJiro Fukae, Kei-Ichi Ishikawa, Taku Hatano, et al.
BMJ Case Reports|June 19, 2012
Atypical Miller Fisher syndrome associated with glutamate receptor antibodiesTaku Hatano, Yoshiaki Shimada, Ayako Kono, et al.
Parkinsonism & Related Disorders|May 4, 2013
Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risksAsako Yoritaka, Yasushi Shimo, Masashi Takanashi, et al.
Internal Medicine (Tokyo, Japan)|August 4, 2017
The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter StudyShinji Ouma, Jiro Fukae, Shinsuke Fujioka, et al.
Clinical Neurology and Neurosurgery|May 19, 2015
Utility of the Japanese version of the 9-item Wearing-off QuestionnaireJiro Fukae, Masa-aki Higuchi, Shosaburo Yanamoto, et al.
Journal of the Neurological Sciences|May 24, 2024
Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER studyNoriko Nishikawa, Taku Hatano, Kenya Nishioka, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Medical Gas Research|February 5, 2019
Inhalation of hydrogen gas elevates urinary 8-hydroxy-2'-deoxyguanine in Parkinson's diseaseMasaaki Hirayama, Mikako Ito, Tomomi Minato, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 10, 2011
Cerebral infarction in a young man using high-dose anabolic steroidsYoshiaki Shimada, Asako Yoritaka, Yasutaka Tanaka, et al.
Parkinsonism & Related Disorders|January 10, 2009
Toxic effects of dopamine metabolism in Parkinson's diseaseNobutaka Hattoria, Mei Wanga, Hikari Taka, et al.
Parkinsonism & Related Disorders|June 10, 2015
Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's diseaseAsako Yoritaka, Sumihiro Kawajiri, Yorihiro Yamamoto, et al.
Journal of Parkinson'S Disease|May 3, 2014
Serum uric acid concentration is linked to wearing-off fluctuation in Japanese Parkinson's disease patientsJiro Fukae, Kei-Ichi Ishikawa, Taku Hatano, et al.
BMJ Case Reports|June 19, 2012
Atypical Miller Fisher syndrome associated with glutamate receptor antibodiesTaku Hatano, Yoshiaki Shimada, Ayako Kono, et al.
Parkinsonism & Related Disorders|May 4, 2013
Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risksAsako Yoritaka, Yasushi Shimo, Masashi Takanashi, et al.
Internal Medicine (Tokyo, Japan)|August 4, 2017
The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter StudyShinji Ouma, Jiro Fukae, Shinsuke Fujioka, et al.
Clinical Neurology and Neurosurgery|May 19, 2015
Utility of the Japanese version of the 9-item Wearing-off QuestionnaireJiro Fukae, Masa-aki Higuchi, Shosaburo Yanamoto, et al.
Journal of the Neurological Sciences|May 24, 2024
Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER studyNoriko Nishikawa, Taku Hatano, Kenya Nishioka, et al.
Pageof 4